Objectives:
Shallow placental implantation (SPI) contributes to adverse pregnancy outcomes. Identification
of histopathological features of SPI, its clinical associations with site specific
implications remains under explored, which forms the basis for this study.
Study Design:
This retrospective study included 182 singleton placentas over 25 weeks of gestation
submitted for histopathological examination. Features of SPI was identified based
on extravillous trophoblast (EVT) persistence in the decidua, parenchyma, or membranes/chorionic
disc. Associations of features of SPI (any SPI, multiple SPI when more than one SPI
lesion was present and site-specific features of SPI), with clinical and placental
outcomes were analyzed.
Results:
Atleast one feature of SPI was present in 58.8% placentas, with multiple features
in 26.9%. The most common site was membranes/chorionic disc(40%). Features of SPI
was present in parenchyma in 24.2% and decidua in 20.3%. Presence of SPI features
was significantly associated with preeclampsia(p=0.0001), fetal growth restriction
(p=0.012), Cesarean delivery(p=0.007), and chronic hypertension(p=0.014) and negatively
with PROM(p=0.0009). Placental findings with significant association were lower placental
weight(p=0.042), infarction (p=0.015), significant fibrin(p=0.005) maternal (p<0.001)and
fetal(p=0.014) vascular malperfusion. The birth weight was significantly lower when
SPI features were present (p=0.013), though no significant difference was observed
in major neonatal morbidities. Basal plate myometrial fibres showed association with
multiple SPI(p=0.023).
Site-specific analysis revealed SPI features in parenchyma to be significantly associated
with oligohydramnios and increased neonatal morbidities (hematological, gastrointestinal,
and overall), in addition to other adverse outcomes associated with SPI. Decidual
features of SPI were additionally associated with maternal diabetes, but showed limited
neonatal impact beyond low birth weight.
Conclusions:
SPI features correlate significantly with major obstetric conditions, birth weight,
and placental vascular pathology. Site-specific analysis shows parenchymal SPI has
the greatest clinical impact, particularly on neonatal morbidities. Recognition and
site-specific documentation enhance its value as an additional parameter within the
MVM spectrum.